α
Journal
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
ISSN: 1740-634X
Titre abrégé: Neuropsychopharmacology
Pays: England
ID NLM: 8904907
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
16
12
2019
accepted:
10
02
2020
revised:
03
02
2020
pubmed:
20
2
2020
medline:
24
6
2021
entrez:
20
2
2020
Statut:
ppublish
Résumé
The α
Identifiants
pubmed: 32074627
doi: 10.1038/s41386-020-0641-z
pii: 10.1038/s41386-020-0641-z
pmc: PMC7360592
doi:
Substances chimiques
Adrenergic Agents
0
Receptors, Adrenergic, alpha-2
0
Guanfacine
30OMY4G3MK
Cocaine
I5Y540LHVR
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1473-1481Subventions
Organisme : NIGMS NIH HHS
ID : T32 GM007628
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK020593
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA042475
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK058404
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY008126
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK059637
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD103537
Pays : United States
Organisme : NIDA NIH HHS
ID : R01DA042475S1
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA068485
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Karlsgodt KH, Lukas SE, Elman I. Psychosocial stress and the duration of cocaine use in non-treatment seeking individuals with cocaine dependence. Am J Drug Alcohol Abus. 2003;29:539–51.
Levandowski ML, Tractenberg SG, de Azeredo LA, De Nardi T, Rovaris DL, Bau CHD, et al. Crack cocaine addiction, early life stress and accelerated cellular aging among women. Prog Neuro-Psychopharmacol Biol Psychiatry. 2016;71:83–9.
Sinha, R, Catapano, D, O’Malley S. Stress-induced craving and stress response in cocaine dependent individuals. Psychoneuroendocrinology.1999; 142:343–51.
Erb S, Hitchcott PK, Rajabi H, Mueller D, Shaham Y, Stewart J. Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology. 2000;23:138–50.
pubmed: 10882840
Shaham Y, Highfield D, Delfs J, Leung S, Stewart J. Clonidine blocks stress-induced reinstatement of heroin seeking in rats: An effect independent of locus coeruleus noradrenergic neurons. Eur J Neurosci. 2000;12:292–302.
pubmed: 10651884
Lê AD, Harding S, Juzytsch W, Funk D, Shaham Y. Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacol (Berl). 2005;179:366–73.
Mantsch JR, Baker DA, Funk D, Lê AD, Shaham Y. Stress-induced reinstatement of drug seeking: 20 years of progress. Neuropsychopharmacology. 2016;41:335–56.
pubmed: 25976297
Fox HC, Seo D, Tuit K, Hansen J, Kimmerling A, Morgan PT, et al. Guanfacine effects on stress, drug craving and prefrontal activation in cocaine dependent individuals: Preliminary findings. J Psychopharmacol. 2012;26:958–72.
pubmed: 22234929
pmcid: 3694403
Fox H, Sinha R. The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals. vol. 69. 1st edn. Elsevier Inc.; 2014.
Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists. Anaesthesia. 1999;54:146–65.
pubmed: 10215710
Seedat YK. Clonidine and guanfacine—comparison of their effects on haemodynamics in hypertension. South Afr Med J. 1985;67:557–9.
Fox HC, Morgan PT, Sinha R. Sex differences in guanfacine effects on drug craving and stress arousal in cocaine-dependent individuals. Neuropsychopharmacology. 2014;39:1527–37.
pubmed: 24395021
pmcid: 3988558
McKee SA, Potenza MN, Kober H, Sofuoglu M, Arnsten AFT, Picciotto MR, et al. A translational investigation targeting stress-reactivity and prefrontal cognitive control with guanfacine for smoking cessation. J Psychopharmacol. 2015;29:300–11.
pubmed: 25516371
Krupitsky E, Zvartau E, Blokhina E, Verbitskaya E, Tsoy M, Wahlgren V, et al. Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia. Drug Alcohol Depend. 2013;132:674–80.
pubmed: 23683793
pmcid: 3971535
Haney M, Cooper ZD, Bedi G, Herrmann E, Comer SD, Reed SC, et al. Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers. Addict Biol. 2019;24:707–16.
pubmed: 29659126
Brown J, Doxey JC, Handley S. Effects of α-adrenoceptor agonists and antagonists and of antidepressant drugs on pre- and postsynaptic a-adrenoceptors. Eur J Pharm. 1980;67:33–40.
Okada M, Fukuyama K, Kawano Y, Shiroyama T, Suzuki D, Ueda Y. Effects of acute and sub-chronic administrations of guanfacine on catecholaminergic transmissions in the orbitofrontal cortex. Neuropharmacology. 2019;156:107547.
pubmed: 30802458
Lee AM, Calarco CA, McKee SA, Mineur YS, Picciotto MR. Variability in nicotine conditioned place preference, stress‐induced reinstatement, and effects of guanfacine in male and female mice. Genes, Brain Behav. 2019;e12601:1–17.
Mantsch JR, Weyer A, Vranjkovic O, Beyer CE, Baker Da, Caretta H. Involvement of noradrenergic neurotransmission in the stress- but not cocaine-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for β−2 adrenergic receptors. Neuropsychopharmacology. 2010;35:2165–78.
pubmed: 20613718
pmcid: 2939933
Vranjkovic O, Gasser PJ, Gerndt CH, Baker DA, Mantsch JR. Stress-Induced Cocaine Seeking Requires a Beta-2 Adrenergic Receptor-Regulated Pathway from the Ventral Bed Nucleus of the Stria Terminalis That Regulates CRF Actions in the Ventral Tegmental Area. J Neurosci. 2014;34:12504–14.
pubmed: 25209288
pmcid: 4160780
Leri F, Flores J, Rodaros D, Stewart J. Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J Neurosci. 2002;22:5713–8.
pubmed: 12097523
pmcid: 6758192
McReynolds JR, Vranjkovic O, Thao M, Baker DA, Makky K, Lim Y, et al. Beta-2 adrenergic receptors mediate stress-evoked reinstatement of cocaine-induced conditioned place preference and increases in CRF mRNA in the bed nucleus of the stria terminalis in mice. Psychopharmacol (Berl). 2014;231:3953–63.
Wang M, Ramos BP, Paspalas CD, Shu Y, Simen A, Duque A, et al. α2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell. 2007;129:397–410.
pubmed: 17448997
Gilsbach R, Albarrán-Juárez J, Hein L. Pre- versus Postsynaptic Signaling by α 2-Adrenoceptors. Curr Top Membr. 2011;67:139–60.
pubmed: 21771489
Alamo C, López-Muñoz F, Sánchez-García J. Mechanism of action of guanfacine: a postsynaptic differential approach to the treatment of attention deficit hyperactivity disorder (adhd). Actas Esp Psiquiatr. 2016;44:107–12.
pubmed: 27254403
Harris NA, Isaac AT, Günther A, Merkel K, Melchior J, Eguakun E, et al. Dorsal BNST α2A -adrenergic receptors produce HCN-dependent excitatory actions that initiate anxiogenic behaviors. J Neurosci. 2018;38:8922–42.
pubmed: 30150361
pmcid: 6191524
Gilsbach R, Röser C, Beetz N, Brede M, Hadamek K, Haubold M, et al. Genetic dissection of α2-adrenoceptor functions in adrenergic versus nonadrenergic cells. Mol Pharmacol. 2009;75:1160–70.
pubmed: 19251826
Paxinos G, Franklin B. The mouse brain in stereotaxic coordinates. Academic Press; 2004.
Fetterly TL, Basu A, Nabit BP, Awad E, Williford KM, Centanni SW, et al. α 2A-adrenergic receptor activation decreases parabrachial nucleus excitatory drive onto BNST CRF neurons and reduces their activity In vivo. J Neurosci 2018;39:472–84.
pubmed: 30478032
Conrad KL, Davis AR, Silber.man Y, Sheffler DJ, Shields AD, Saleh Sa, et al. Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes. Neuropsychopharmacology. 2012;37:2253–66.
pubmed: 22617356
pmcid: 3422490
Davis AR, Shields AD, Brigman JL, Norcross M, McElligott ZA, Holmes A, et al. Yohimbine impairs extinction of cocaine-conditioned place preference in an α2-adrenergic receptor independent process. Learn Mem. 2008;15:667–76.
pubmed: 18772254
pmcid: 2632785
Erb S, Stewart J. A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. J Neurosci. 1999;19:1–6.
Vranjkovic O, Pina M, Kash TL, Winder DG. The bed nucleus of the stria terminalis in drug-associated behavior and affect: a circuit-based perspective. Neuropharmacology. 2017;122:100–6.
pubmed: 28351600
pmcid: 5481847
Crowley NA, Bloodgood DW, Hardaway JA, Kendra AM, McCall JG, Al-Hasani R, et al. Dynorphin Controls the Gain of an Amygdalar Anxiety Circuit. Cell Rep. 2016;14:2774–83.
pubmed: 26997280
pmcid: 4814306
Avery SN, Clauss JA, Blackford JU. The Human BNST: Functional Role in Anxiety and Addiction. Neuropsychopharmacology. 2016;41:126–41.
pubmed: 26105138
Clauss JA, Avery SN, Benningfield MM, Blackford JU. Social anxiety is associated with BNST response to unpredictability. Depress Anxiety. 2019; 36:666–75.
Mineur YS, Bentham MP, Zhou WL, Plantenga ME, McKee SA, Picciotto MR. Antidepressant-like effects of guanfacine and sex-specific differences in effects on c-fos immunoreactivity and paired-pulse ratio in male and female mice. Psychopharmacol (Berl). 2015;232:3539–49.
Mineur YS, Cahuzac EL, Mose TN, Bentham MP, Plantenga ME, Thompson DC, et al. Interaction between noradrenergic and cholinergic signaling in amygdala regulates anxiety- and depression-related behaviors in mice. Neuropsychopharmacology. 2018;43:2118–25.
pubmed: 29472646
pmcid: 6098039
Fiks AG, Mayne SL, Song L, Steffes J, Liu W, McCarn B, et al. Changing patterns of alpha agonist medication use in children and adolescents 2009–11. J Child Adolesc Psychopharmacol. 2015;25:362–7.
pubmed: 25919708
pmcid: 4442562
Gowing L, Farrell M, Ali R, Jm W. Alpha2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database of Systematic Reviews 2009. https://doi.org/10.1002/14651858.CD002024.pub3 .
Cecchi M, Khoshbouei H, Javors M, Morilak DA. Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuroscience. 2002;112:13–21.
pubmed: 12044468
Schmidt KT, Makhijani VH, Boyt KM, Cogan ES, Pati D, Pina MM, et al. Stress-Induced Alterations of Norepinephrine Release in the Bed Nucleus of the Stria Terminalis of Mice. ACS Chem Neurosci. 2019;10:1908–14.
pubmed: 30252438
Pleil KE, Rinker Ja, Lowery-Gionta EG, Mazzone CM, McCall NM, Kendra AM, et al. NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking. Nat Neurosci 2015;18:545–52.
pubmed: 25751534
pmcid: 4376619
Rinker JA, Marshall SA, Mazzone CM, Lowery-Gionta EG, Gulati V, Pleil KE, et al. Extended amygdala to ventral tegmental area corticotropin-releasing factor circuit controls binge ethanol intake. Biol Psychiatry. 2017;81:930–40.
pubmed: 27113502
Pina MM, Young EA, Ryabinin AE, Cunningham CL. The bed nucleus of the stria terminalis regulates ethanol-seeking behavior in mice. Neuropharmacology. 2015;99:627–38.
pubmed: 26302652
pmcid: 4668125
Companion MA, Thiele TE. Assessment of ventral tegmental area-projecting GABAergic neurons from the bed nucleus of the stria terminalis in modulating binge-like ethanol intake. Eur J Neurosci. 2018;48:3335–43.
pubmed: 30362199
pmcid: 6312688
Abercrombie ED, Keller RW, Zigmond MJ. Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience. 1988;27:897–904.
pubmed: 3252176
Winter JC, Rabin RA. Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination. J Pharm Exp Ther. 1992;263:682–9.
Nair SG, Navarre BM, Cifani C, Pickens CL, Bossert JM, Shaham Y. Role of dorsal medial prefrontal cortex dopamine D1-family receptors in relapse to high-fat food seeking induced by the anxiogenic drug Yohimbine. Neuropsychopharmacology. 2011;36:497–510.
pubmed: 20962767
Dzung Lê A, Funk D, Harding S, Juzytsch W, Fletcher PJ. The role of noradrenaline and 5-hydroxytryptamine in yohimbine-induced increases in alcohol-seeking in rats. Psychopharmacol (Berl). 2009;204:477–88.
Verplaetse TL, Roberts W, Moore KE, Peltier MR, Oberleitner LM, McKee SA. Pharmacokinetics and pharmacodynamics of immediate-release versus extended-release guanfacine in adult daily smokers. J Clin Psychopharmacol. 2019;39:124–8.
pubmed: 30707118
pmcid: 6391212
Barcelos NM, Van Ness PH, Wagner AF, MacAvoy MG, Mecca AP, Anderson GM, et al. Guanfacine treatment for prefrontal cognitive dysfunction in older participants: a randomized clinical trial. Neurobiol Aging. 2018;70:117–24.
pubmed: 30007160
pmcid: 6503670